|
|
 |
|
Viewing report
|
|
|
|
Barrier Therapeutics, Inc. (Inactive): SWOT Analysis & Company Profile
Business Review, Jan 2011, Pages: 30
Synopsis
Business Review’s Barrier Therapeutics, Inc. (Inactive) contains a company overview, key facts, locations and subsidiaries, news and events as well as a SWOT analysis of the company.
Summary
This SWOT Analysis company profile is a crucial resource for industry executives and anyone looking to quickly understand the key information concerning Barrier Therapeutics, Inc. (Inactive)’s business.
Business Review’s “Barrier Therapeutics, Inc. (Inactive) SWOT Analysis & Company Profile” reports utilize a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format.
Business Review strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Scope
- Examines and identifies key information and issues about (Barrier Therapeutics, Inc. (Inactive)) for business intelligence requirements
- Studies and presents Barrier Therapeutics, Inc. (Inactive)’s strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
- The profile contains business operations, the company history, major products and services, prospects, key competitors, structure and key employees, locations and subsidiaries.
Reasons To Buy
- Quickly enhance your understanding of the company.
- Obtain details and analysis of the market and competitors as well as internal and external factors which could impact the industry.
- Increase business/sales activities by understanding your competitors’ businesses better.
- Recognize potential partnerships and suppliers.
- Obtain yearly profitability figures
Key Highlights
Barrier Therapeutics (Barrier) is a pharmaceutical company engaged in the research, development and commercialization of pharmaceutical products related to the dermatology. The company is headquartered at Princeton in New Jersey, the US and has its operations in the US, Canada and Belgium. In August 2008, the company was acquired by Stiefel Laboratories, Inc.
|
|
|
|
